• Investor Presentation
• Fact Sheet
• Financial Information
  • Quarterly Results
  • Annual Reports/Proxy
  • SEC Filings
  • Financial News
• Stock Information
  • Stock Performance
  • Historic Stock Lookup
  • Investment Calculator
  • Analyst Coverage
• Direct Stock Purchase
• Shareholder Services
  • Investor FAQs
  • Shareholder Electronic Delivery
  • Contact Us
• Corporate Governance
  • Board of Directors
  • Committees & Charters
  • Insider Transactions
  • Insider Ownership

Investor Relations

Insider Stock Ownership

Name	Relationship / Title	Current Shares	Trading Activity
dunbar, george w.	Officer	30,000	View
Date	Type	Shares Traded	Price Range USD
11/12/2007	Buy	20,000	0.90
05/11/2007	Buy	10,000	1.45
mayleben, timothy m.	Director	6,900	View
Date	Type	Shares Traded	Price Range USD
11/01/2005	Acquisition (Non Open Market)	6,900	n/a
rubino, alan l.	Director	6,900	View
Date	Type	Shares Traded	Price Range USD
11/01/2005	Acquisition (Non Open Market)	6,900	n/a
sims, nelson m.	Director	79,800	View
Date	Type	Shares Traded	Price Range USD
02/12/2008	Acquisition (Non Open Market)	64,300	n/a
11/12/2007	Buy	10,000	0.90
02/09/2006	Acquisition (Non Open Market)	5,500	n/a
sudovar, stephen g.	Director	26,900	View
Date	Type	Shares Traded	Price Range USD
09/14/2007	Buy	10,000	1.12
05/18/2006	Buy	10,000	1.37
11/01/2005	Acquisition (Non Open Market)	6,900	n/a
wyant, pharm. d., susan l.	Director	6,900	View
Date	Type	Shares Traded	Price Range USD
11/01/2005	Acquisition (Non Open Market)	6,900	n/a
zerbe, m.d., robert l.	Director	7,200	View
Date	Type	Shares Traded	Price Range USD
01/16/2006	Acquisition (Non Open Market)	7,200	n/a

Stock transaction information provided by EDGAR Online. Aastrom Biosciences, Inc. makes no representation or warranty with respect any of to the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.